Ketoconazole (systemic) vs Pazopanib

Interacting Drugs
Ketoconazole (systemic)
Security Level
Moderate, Consider therapy modification
Pazopanib: CYP3A4 Inhibitors (Strong) may increase the serum concentration of Pazopanib.
Avoid concurrent use of pazopanib with strong inhibitors of CYP3A4 whenever possible. If it is not possible to avoid such a combination, reduce pazopanib adult dose to 400 mg. Further dose reductions may also be required.

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Ketoconazole (systemic) vs Pazopanib